Failure to follow ordered treatments, insulin site rotation, and CGM orders
Summary
The facility failed to provide appropriate treatment and care according to physician orders, resident preferences, and goals for four sampled residents. The report states that these failures affected Resident 17, Resident 8, Resident 37, and Resident 68, and that the residents did not attain and maintain their highest practicable physical well-being. The deficiencies involved wound and skin treatment management, insulin injection site rotation, and the use and care of a blood glucose monitoring device. For Resident 17, the medical record showed physician orders for therapeutic coal tar shampoo and multiple topical treatments for dermatologic rash/open lesions on the right lower extremity and right upper extremity, torso, and back, along with doxycycline for impetigo. After a dermatology visit, the resident was diagnosed with prurigo nodularis with self-inflicted scratching/picking. The record did not show that the resident’s treatments were updated to reflect the new diagnosis and instead continued to reflect treatment for a dermatological rash. During review of the treatment cart and records, the LVN and RN verified the diagnosis of prurigo nodularis but could not show documentation that the treatments were updated. The LVN also showed a therapeutic shampoo with 0.5% coal tar even though the order specified 3% coal tar. For Resident 8 and Resident 37, physician orders required insulin to be administered subcutaneously and for injection sites to be rotated. Review of the blood glucose monitoring and location of administration records showed repeated use of the same sites rather than rotation. Resident 8 received regular insulin multiple times in the left arm and later multiple times in the left lower abdominal quadrant. Resident 37 received Humulin-R and insulin glargine repeatedly in the left lower quadrant of the abdomen on several occasions. RN 1 verified the findings and stated the injection sites should have been rotated with each administration. The DON was informed and acknowledged the findings. For Resident 68, the resident had a Dexcom G7 blood sugar monitoring device observed at the bedside and stated that the nurses helped apply the dressing and that the device was used to show blood sugar results. The record contained an order for Lispro insulin by sliding scale, but it did not contain a physician’s order for use of the Dexcom device or documented care instructions for the probe site. Staff interviews confirmed that the resident had the device, that finger sticks were still being used and compared, and that there was no physician order for the Dexcom G7 or care of the skin where the probe was placed.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.